Literature DB >> 2813795

Spinal cord sarcoidosis: a new finding at MR imaging with Gd-DTPA enhancement.

G M Nesbit1, G M Miller, H L Baker, M J Ebersold, B W Scheithauer.   

Abstract

Three patients with histologically confirmed sarcoidosis with spinal cord involvement were examined with high-field-strength magnetic resonance imaging (1.5 T) before and after the administration of gadolinium diethylenetriaminepentaacetic acid. In addition to intramedullary expansion, areas of patchy, multifocal, parenchymal enhancement and areas of linear peripheral enhancement were seen in all three patients; these findings have not been previously reported and are unusual for other more common spinal cord lesions. This observation led to a correct diagnosis and a limitation of the extent of biopsy in two of the cases. Unfortunately, this enhancement pattern is not specific for sarcoidosis, as the authors have observed similar findings in two cases of biopsy-proved myelitis and multiple sclerosis. The peripheral enhancement is thought to be located in the leptomeninges due to leptomeningeal involvement, which was proved histologically in one case. This pattern of involvement, while not specific, is certainly consistent with and, in the appropriate clinical setting, highly suggestive of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813795     DOI: 10.1148/radiology.173.3.2813795

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

Review 1.  Sarcoidosis of the spinal cord: literature review and report of eight cases.

Authors:  Samer Saleh; Chandan Saw; Kamel Marzouk; Om Sharma
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

Review 2.  Imaging findings in spinal sarcoidosis: a report of 18 cases and review of the current literature.

Authors:  Neetu Soni; Girish Bathla; Ravishankar Pillenahalli Maheshwarappa
Journal:  Neuroradiol J       Date:  2018-10-12

3.  Magnetic resonance imaging in spinal emergency.

Authors:  D Koch; A K Wakhloo; V van Velthoven
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Case report 825. Leptomeningeal and spinal-pelvic osseous sarcoidosis.

Authors:  C Le Breton; J P Ferroir; J Cadranel; M Antoine; J L Le Quintrec; F Carbonnel; J M Bigot
Journal:  Skeletal Radiol       Date:  1994-05       Impact factor: 2.199

5.  A single focus of probable multiple sclerosis in the cervical spinal cord mimicking a tumour.

Authors:  A Meurice; P Flandroy; R F Dondelinger; M Reznik
Journal:  Neuroradiology       Date:  1994-04       Impact factor: 2.804

6.  Spinal intradural extramedullary capillary hemangioma: MR imaging findings.

Authors:  B Y Choi; K H Chang; G Choe; M H Han; S W Park; I K Yu; Y H Park; H J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

7.  Spinal cord and cauda equina MRI findings in metachromatic leukodystrophy: case report.

Authors:  Irene Toldo; Carla Carollo; Pier Antonio Battistella; Anna Maria Laverda
Journal:  Neuroradiology       Date:  2005-07-15       Impact factor: 2.804

8.  Is extensive cervical laminoplasty an effective treatment for spinal cord sarcoidosis combined with cervical spondylosis?

Authors:  Keisuke Oe; Minoru Doita; Hiroshi Miyamoto; Fumio Kanda; Masahiro Kurosaka; Masatoshi Sumi
Journal:  Eur Spine J       Date:  2009-02-12       Impact factor: 3.134

9.  Neurosarcoidosis without systemic sarcoidosis.

Authors:  N Sommer; M Weller; D Petersen; H Wiethölter; J Dichgans
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

10.  Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients.

Authors:  Cécile-Audrey Durel; Romain Marignier; Delphine Maucort-Boulch; Jean Iwaz; Emilie Berthoux; Marc Ruivard; Marc André; Guillaume Le Guenno; Laurent Pérard; Jean-François Dufour; Alin Turcu; Jean-Christophe Antoine; Jean-Philippe Camdessanche; Thierry Delboy; Pascal Sève
Journal:  J Neurol       Date:  2016-03-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.